top of page
KPI Banner.jpg

Key Performance Indicators for IPC
by Prof Dr Amir Monir Ali, Director of the Central Quality Administration, Mansoura University Hospitals 

Infection prevention and control (IPC) is a critical component of healthcare quality and patient safety, aimed at reducing healthcare-associated infections (HAIs), antimicrobial resistance, and other risks in healthcare settings. Key Performance Indicators (KPIs) provide measurable metrics to evaluate IPC programs, track progress, and drive improvements. Based on guidelines and resources from the Centers for Disease Control and Prevention (CDC), the World Health Organization (WHO), the Association for Professionals in Infection Control and Epidemiology (APIC), the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and other international organizations, this report presents a logical classification of KPIs.The classification follows the Donabedian model, a widely used framework in healthcare quality assessment.

​

This model categorizes indicators into three domains:

  • Structure Indicators: Focus on the resources, organization, and infrastructure available for IPC (e.g., staffing, training, and facilities).

  • Process Indicators: Measure adherence to IPC practices and protocols (e.g., compliance with hand hygiene or disinfection procedures).

  • Outcome Indicators: Assess the results of IPC efforts, such as infection rates or patient outcomes.

This approach ensures a comprehensive view of IPC effectiveness, from foundational elements to tangible impacts. The KPIs listed below are derived from authoritative sources, including CDC's National Healthcare Safety Network (NHSN), WHO's IPC guidelines, APIC's competency models, SHEA/IDSA compendiums, and related surveys like the PROHIBIT study. Over 30 KPIs are included, representing a broad compilation to cover surveillance, prevention, and stewardship aspects in hospitals and other settings.

​

​Structure Indicators

These KPIs evaluate the foundational elements of an IPC program, such as human resources, training, and infrastructure. They are essential for ensuring that healthcare facilities have the capacity to implement effective IPC measures.

​​​​​​

Picture1.png

Process Indicators

These KPIs track adherence to evidence-based practices and protocols, focusing on behaviors and activities that prevent infections. They are often measured through observations, audits, or consumption tracking.

Picture2.png

Outcome Indicators

These KPIs measure the direct results of IPC efforts, such as reduced infection rates or improved patient safety metrics. They often use standardized ratios like the Standardized Infection Ratio (SIR) from CDC's NHSN.

Picture3.png

Structure Indicators

 

1. Full-Time Equivalent (FTE) Infection Control Nurses per 1,000 Beds

  1. Indicator Title: Full-Time Equivalent (FTE) Infection Control Nurses per 1,000 Beds

  2. Definition: Ratio of dedicated infection prevention staff to hospital beds.

    • Inclusion Criteria: All full-time equivalent positions for infection control nurses or preventionists.

    • Exclusion Criteria: Non-dedicated staff, part-time roles not converted to FTE, or non-nursing IPC personnel.

  3. Quality Dimension: Efficiency, Safety

  4. Indicator Type: Structure

  5. Sampling Techniques: Facility-wide census of staffing and bed counts.

  6. Formula: (Number of FTE IPC nurses / Total inpatient beds) × 1,000

  7. Frequency: Annually

  8. Source of Data: Human resources records, hospital administration data

  9. Methodology: Collect FTE data from HR and bed counts from facility reports; calculate ratio and compare to benchmarks.

  10. Target / Benchmark: 1 FTE per 100-250 beds (APIC Staffing Calculator)

    2 sources

  11. Explanation: This KPI assesses staffing adequacy to support IPC surveillance and interventions, ensuring resources match facility size and complexity to prevent infections effectively.

 

2. Staff Training Completion Rate for IPC Practices

  1. Indicator Title: Staff Training Completion Rate for IPC Practices

  2. Definition: Percentage of healthcare workers completing mandatory IPC training.

    • Inclusion Criteria: All clinical staff required to undergo IPC training (e.g., on hand hygiene, isolation).

    • Exclusion Criteria: Non-clinical staff, incomplete or expired trainings.

  3. Quality Dimension: Effectiveness, Safety

  4. Indicator Type: Structure

  5. Sampling Techniques: Review of all eligible staff training records.

  6. Formula: (Number of staff completing training / Total eligible staff) × 100

  7. Frequency: Annually or semi-annually

  8. Source of Data: Hospital training records, HR database

  9. Methodology: Verify completion via online modules or workshops; calculate rate and identify gaps.

  10. Target / Benchmark: 95-100% completion (CDC Core Practices)

    2 sources

  11. Explanation: This KPI ensures staff are equipped with IPC knowledge, reducing errors and enhancing adherence to protocols like hand hygiene.

 

3. Proportion of Healthcare Personnel Immunized (e.g., Influenza, Hepatitis B)

  1. Indicator Title: Proportion of Healthcare Personnel Immunized (e.g., Influenza, Hepatitis B)

  2. Definition: Percentage of staff vaccinated against preventable diseases.

    • Inclusion Criteria: All healthcare personnel eligible for vaccination.

    • Exclusion Criteria: Staff with medical contraindications or declinations.

  3. Quality Dimension: Safety, Effectiveness

  4. Indicator Type: Structure

  5. Sampling Techniques: Facility-wide review of vaccination records.

  6. Formula: (Number of immunized staff / Total eligible staff) × 100

  7. Frequency: Annually

  8. Source of Data: Immunization records, employee health services

  9. Methodology: Track vaccinations through records; calculate coverage and follow up on gaps.

  10. Target / Benchmark: 90% for influenza (CDC recommendations)

    2 sources

  11. Explanation: This KPI reduces transmission risks by ensuring staff immunity, protecting both personnel and patients from vaccine-preventable infections.

 

4. Availability of IPC Resources (e.g., PPE Stock Levels)

  1. Indicator Title: Availability of IPC Resources (e.g., PPE Stock Levels)

  2. Definition: Adequacy of supplies like PPE and hand hygiene products.

    • Inclusion Criteria: Essential IPC items (masks, gloves, sanitizers).

    • Exclusion Criteria: Non-IPC resources or expired stock.

  3. Quality Dimension: Safety, Efficiency

  4. Indicator Type: Structure

  5. Sampling Techniques: Inventory audits of storage areas.

  6. Formula: (Available stock / Required minimum stock) × 100

  7. Frequency: Quarterly

  8. Source of Data: Supply chain logs, inventory systems

  9. Methodology: Audit stock levels against usage forecasts; calculate adequacy ratio.

  10. Target / Benchmark: 100% availability, with 3-month buffer (WHO Minimum Requirements)

    2 sources

  11. Explanation: This KPI ensures facilities have sufficient resources for IPC practices, preventing shortages that could compromise safety during outbreaks.

 

5. Multidisciplinary IPC Team Involvement

  1. Indicator Title: Multidisciplinary IPC Team Involvement

  2. Definition: Presence and activity of a cross-functional IPC team.

    • Inclusion Criteria: Teams with physicians, nurses, administrators.

    • Exclusion Criteria: Single-discipline or inactive teams.

  3. Quality Dimension: Effectiveness, Patient-centeredness

  4. Indicator Type: Structure

  5. Sampling Techniques: Review of team meeting minutes and membership.

  6. Formula: (Number of active multidisciplinary meetings / Total planned meetings) × 100

  7. Frequency: Quarterly

  8. Source of Data: Committee records, meeting logs

  9. Methodology: Assess team composition and activity; calculate involvement rate.

  10. Target / Benchmark: 100% involvement in decision-making (SHEA/APIC Position Paper)

    2 sources

  11. Explanation: This KPI promotes collaborative IPC decision-making, integrating diverse expertise to enhance program effectiveness.

 

6. Facility Infrastructure for Isolation (e.g., Single Rooms per Total Beds)

  1. Indicator Title: Facility Infrastructure for Isolation (e.g., Single Rooms per Total Beds)

  2. Definition: Ratio of isolation-capable rooms to total beds.

    • Inclusion Criteria: Rooms meeting isolation standards (e.g., negative pressure).

    • Exclusion Criteria: Non-isolation rooms or shared spaces.

  3. Quality Dimension: Safety, Timeliness

  4. Indicator Type: Structure

  5. Sampling Techniques: Facility blueprint review.

  6. Formula: (Number of isolation rooms / Total beds) × 100

  7. Frequency: Annually

  8. Source of Data: Facility engineering records

  9. Methodology: Count compliant rooms; calculate ratio against total capacity.

  10. Target / Benchmark: 5-10% of beds as single/isolation (CDC Isolation Guidelines)

    2 sources

  11. Explanation: This KPI evaluates infrastructure for containing infections, supporting timely isolation to prevent transmission.

 

Process Indicators

​

1. Hand Hygiene Compliance Rate

  1. Indicator Title: Hand Hygiene Compliance Rate

  2. Definition: Percentage of observed opportunities where hand hygiene is performed correctly.

    • Inclusion Criteria: All WHO "5 Moments" for hand hygiene.

    • Exclusion Criteria: Moments where hygiene is not required.

  3. Quality Dimension: Safety, Effectiveness

  4. Indicator Type: Process

  5. Sampling Techniques: Direct random observations.

  6. Formula: (Compliant actions / Total opportunities) × 100

  7. Frequency: Monthly

  8. Source of Data: Observation audits by trained staff

  9. Methodology: Observe and record compliance; calculate rate and track trends.

  10. Target / Benchmark: ≥80% (WHO guidelines)

    2 sources

  11. Explanation: This KPI monitors adherence to hand hygiene, a primary measure to prevent infection spread in healthcare settings.

 

2. Alcohol-Based Hand Rub Consumption (ABHRC)

  1. Indicator Title: Alcohol-Based Hand Rub Consumption (ABHRC)

  2. Definition: Volume of ABHR used per patient-days.

    • Inclusion Criteria: All ABHR dispensed in clinical areas.

    • Exclusion Criteria: Non-clinical use or other sanitizers.

  3. Quality Dimension: Effectiveness, Safety

  4. Indicator Type: Process

  5. Sampling Techniques: Total facility consumption tracking.

  6. Formula: (Liters of ABHR used / Patient-days) × 1,000

  7. Frequency: Monthly

  8. Source of Data: Supply logs, purchasing records

  9. Methodology: Track usage volume; normalize to patient-days.

  10. Target / Benchmark: >20 L per 1,000 patient-days (WHO)

    2 sources

  11. Explanation: This KPI indicates hygiene activity levels, correlating with compliance to reduce infections.

 

3. Adherence to Disinfection/Sterilization Guidelines

  1. Indicator Title: Adherence to Disinfection/Sterilization Guidelines

  2. Definition: Percentage of procedures compliant with protocols.

    • Inclusion Criteria: All reprocessing of medical devices.

    • Exclusion Criteria: Non-reprocessable items.

  3. Quality Dimension: Safety, Effectiveness

  4. Indicator Type: Process

  5. Sampling Techniques: Random audits of procedures.

  6. Formula: (Compliant procedures / Total observed) × 100

  7. Frequency: Quarterly

  8. Source of Data: Audit reports, central sterile services

  9. Methodology: Observe reprocessing; assess against CDC guidelines.

  10. Target / Benchmark: 100% compliance (CDC Disinfection Guideline)

    2 sources

  11. Explanation: This KPI ensures devices are free of pathogens, preventing HAIs from contaminated equipment.

 

4. Proper Sharps Disposal Compliance Rate

  1. Indicator Title: Proper Sharps Disposal Compliance Rate

  2. Definition: Percentage of sharps disposed in designated containers.

    • Inclusion Criteria: All used sharps in procedures.

    • Exclusion Criteria: Non-sharp waste.

  3. Quality Dimension: Safety

  4. Indicator Type: Process

  5. Sampling Techniques: Random inspections of disposal areas.

  6. Formula: (Correctly disposed sharps / Total sharps observed) × 100

  7. Frequency: Monthly

  8. Source of Data: Waste audits, incident reports

  9. Methodology: Inspect containers for proper use; calculate compliance.

  10. Target / Benchmark: 98-100% (WHO Injection Safety)

    2 sources

  11. Explanation: This KPI prevents needlestick injuries and pathogen transmission by ensuring safe disposal.

 

5. Environmental Cleaning Compliance Rate

  1. Indicator Title: Environmental Cleaning Compliance Rate

  2. Definition: Percentage of surfaces cleaned per protocols.

    • Inclusion Criteria: High-touch surfaces in patient areas.

    • Exclusion Criteria: Low-risk areas or non-patient zones.

  3. Quality Dimension: Safety, Effectiveness

  4. Indicator Type: Process

  5. Sampling Techniques: Audits using fluorescent markers.

  6. Formula: (Compliant cleaned surfaces / Total audited) × 100

  7. Frequency: Monthly

  8. Source of Data: Cleaning logs, audit tools

  9. Methodology: Mark surfaces, check removal after cleaning; calculate rate.

  10. Target / Benchmark: ≥90% (CDC Environmental Cleaning)

    2 sources

  11. Explanation: This KPI reduces environmental contamination, lowering HAI risks from surfaces.

 

6. PPE Usage Compliance Rate

  1. Indicator Title: PPE Usage Compliance Rate

  2. Definition: Percentage of instances where appropriate PPE is used.

    • Inclusion Criteria: High-risk procedures requiring PPE.

    • Exclusion Criteria: Low-risk activities.

  3. Quality Dimension: Safety

  4. Indicator Type: Process

  5. Sampling Techniques: Direct observations during procedures.

  6. Formula: (Compliant PPE uses / Total opportunities) × 100

  7. Frequency: Quarterly

  8. Source of Data: Audit reports

  9. Methodology: Observe usage; assess against protocols.

  10. Target / Benchmark: 100% (CDC PPE Guidelines)

    2 sources

  11. Explanation: This KPI ensures protection against transmission during patient care.

 

7. Isolation Precautions Compliance Rate

  1. Indicator Title: Isolation Precautions Compliance Rate

  2. Definition: Percentage of patients managed per isolation guidelines.

    • Inclusion Criteria: Patients under standard/contact/droplet precautions.

    • Exclusion Criteria: Non-isolated patients.

  3. Quality Dimension: Safety, Timeliness

  4. Indicator Type: Process

  5. Sampling Techniques: Random patient audits.

  6. Formula: (Compliant isolations / Total isolated patients) × 100

  7. Frequency: Monthly

  8. Source of Data: Patient records, audits

  9. Methodology: Review adherence to protocols; calculate rate.

  10. Target / Benchmark: 100% (CDC Isolation Guidelines)

    2 sources

  11. Explanation: This KPI prevents spread of infections through proper isolation.

 

8. Antibiotic Stewardship Compliance (e.g., Appropriate Prescription Rate)

  1. Indicator Title: Antibiotic Stewardship Compliance (e.g., Appropriate Prescription Rate)

  2. Definition: Percentage of prescriptions meeting criteria.

    • Inclusion Criteria: All antibiotic prescriptions.

    • Exclusion Criteria: Non-antibiotic medications.

  3. Quality Dimension: Effectiveness, Safety

  4. Indicator Type: Process

  5. Sampling Techniques: Random chart reviews.

  6. Formula: (Appropriate prescriptions / Total prescriptions) × 100

  7. Frequency: Quarterly

  8. Source of Data: Pharmacy records, charts

  9. Methodology: Audit prescriptions against guidelines; calculate rate.

  10. Target / Benchmark: ≥90% (CDC Core Elements)

    2 sources

  11. Explanation: This KPI reduces resistance by ensuring judicious antibiotic use.

 

9. Waste Segregation Accuracy

  1. Indicator Title: Waste Segregation Accuracy

  2. Definition: Percentage of waste correctly segregated.

    • Inclusion Criteria: All medical waste.

    • Exclusion Criteria: Non-medical waste.

  3. Quality Dimension: Safety, Efficiency

  4. Indicator Type: Process

  5. Sampling Techniques: Random waste bin audits.

  6. Formula: (Correctly segregated items / Total items audited) × 100

  7. Frequency: Quarterly

  8. Source of Data: Waste management logs

  9. Methodology: Inspect segregation; calculate accuracy.

  10. Target / Benchmark: 95% (WHO guidelines)

    2 sources

  11. Explanation: This KPI minimizes infection risks from improper waste handling.

 

10. Carbapenemase-Producing Enterobacteriaceae (CPE) Testing Compliance

  1. Indicator Title: Carbapenemase-Producing Enterobacteriaceae (CPE) Testing Compliance

  2. Definition: Percentage of eligible patients screened for CPE.

    • Inclusion Criteria: High-risk patients (e.g., transfers).

    • Exclusion Criteria: Low-risk or previously screened.

  3. Quality Dimension: Safety, Effectiveness

  4. Indicator Type: Process

  5. Sampling Techniques: Review of high-risk admissions.

  6. Formula: (Screened patients / Eligible patients) × 100

  7. Frequency: Monthly

  8. Source of Data: Lab and admission records

  9. Methodology: Track screening; calculate compliance.

  10. Target / Benchmark: 100% for high-risk (WHO/ECDC)

    2 sources

  11. Explanation: This KPI enables early detection of resistant organisms.

 

11. Feedback on MDRO Rates to Clinical Units

  1. Indicator Title: Feedback on MDRO Rates to Clinical Units

  2. Definition: Frequency of reporting MDRO data to wards.

    • Inclusion Criteria: All MDRO surveillance reports.

    • Exclusion Criteria: Non-MDRO data.

  3. Quality Dimension: Effectiveness, Timeliness

  4. Indicator Type: Process

  5. Sampling Techniques: Review of feedback logs.

  6. Formula: (Feedback instances / Planned instances) × 100

  7. Frequency: Quarterly

  8. Source of Data: Surveillance reports

  9. Methodology: Track distribution; calculate coverage.

  10. Target / Benchmark: 100% timely feedback (PROHIBIT Survey)

    2 sources

  11. Explanation: This KPI supports unit-level actions to control MDROs.

 

Outcome Indicators

 

1. Surgical Site Infection (SSI) Rate

  1. Indicator Title: Surgical Site Infection (SSI) Rate

  2. Definition: Number of SSIs per surgical procedures.

    • Inclusion Criteria: All surgical procedures.

    • Exclusion Criteria: Pre-existing infections, minor procedures.

  3. Quality Dimension: Safety, Effectiveness

  4. Indicator Type: Outcome

  5. Sampling Techniques: All eligible procedures.

  6. Formula: (SSIs / Procedures) × 100

  7. Frequency: Quarterly

  8. Source of Data: Surveillance, medical records

  9. Methodology: Prospective surveillance; calculate SIR.

  10. Target / Benchmark: Procedure-specific medians (CDC NHSN)

    2 sources

  11. Explanation: This KPI tracks post-surgical infections, guiding improvements in operative practices.

 

2. Central Line-Associated Bloodstream Infection (CLABSI) Rate

  1. Indicator Title: Central Line-Associated Bloodstream Infection (CLABSI) Rate

  2. Definition: Number of CLABSIs per central line-days.

    • Inclusion Criteria: Bloodstream infections linked to central lines.

    • Exclusion Criteria: Infections present on admission.

  3. Quality Dimension: Safety, Effectiveness

  4. Indicator Type: Outcome

  5. Sampling Techniques: All central line patients.

  6. Formula: (CLABSIs / Central line-days) × 1,000

  7. Frequency: Quarterly

  8. Source of Data: Lab reports, records

  9. Methodology: Identify events using LCBI criteria; calculate SIR.

  10. Target / Benchmark: 0, or facility-specific (CDC NHSN)

    2 sources

  11. Explanation: This KPI monitors line-related infections in critical care.

 

3. Catheter-Associated Urinary Tract Infection (CAUTI) Rate

  1. Indicator Title: Catheter-Associated Urinary Tract Infection (CAUTI) Rate

  2. Definition: Number of CAUTIs per catheter-days.

    • Inclusion Criteria: UTIs linked to urinary catheters.

    • Exclusion Criteria: Infections present on admission.

  3. Quality Dimension: Safety, Effectiveness

  4. Indicator Type: Outcome

  5. Sampling Techniques: All catheterized patients.

  6. Formula: (CAUTIs / Catheter-days) × 1,000

  7. Frequency: Quarterly

  8. Source of Data: Lab, records

  9. Methodology: Apply UTI criteria; calculate rate.

  10. Target / Benchmark: <1 per 1,000 (CDC NHSN)

    2 sources

  11. Explanation: This KPI reduces catheter-related UTIs through better practices.

 

4. Ventilator-Associated Events (VAE)/Pneumonia (VAP) Rate

  1. Indicator Title: Ventilator-Associated Events (VAE)/Pneumonia (VAP) Rate

  2. Definition: Number of VAEs/VAPs per ventilator-days.

    • Inclusion Criteria: Events in ventilated patients.

    • Exclusion Criteria: Non-ventilator pneumonias.

  3. Quality Dimension: Safety, Effectiveness

  4. Indicator Type: Outcome

  5. Sampling Techniques: All ventilated patients.

  6. Formula: (VAEs / Ventilator-days) × 1,000

  7. Frequency: Quarterly

  8. Source of Data: ICU records, lab

  9. Methodology: Use PNEU/VAE criteria; calculate rate.

  10. Target / Benchmark: 0-5 per 1,000 (CDC NHSN)

    2 sources

  11. Explanation: This KPI focuses on ventilator complications in ICUs.

 

5. Clostridium Difficile Infection (CDI) Rate

  1. Indicator Title: Clostridium Difficile Infection (CDI) Rate

  2. Definition: Number of CDIs per patient-days.

    • Inclusion Criteria: Hospital-onset CDIs.

    • Exclusion Criteria: Community-onset cases.

  3. Quality Dimension: Safety, Effectiveness

  4. Indicator Type: Outcome

  5. Sampling Techniques: All positive lab tests.

  6. Formula: (CDIs / Patient-days) × 10,000

  7. Frequency: Quarterly

  8. Source of Data: Lab reports

  9. Methodology: Use LabID criteria; calculate SIR.

  10. Target / Benchmark: SIR <1 (CDC NHSN)

    2 sources

  11. Explanation: This KPI tracks antibiotic-related diarrhea infections.

 

6. Methicillin-Resistant Staphylococcus Aureus (MRSA) Bacteremia Rate

  1. Indicator Title: Methicillin-Resistant Staphylococcus Aureus (MRSA) Bacteremia Rate

  2. Definition: Number of MRSA bacteremias per patient-days.

    • Inclusion Criteria: Hospital-acquired MRSA blood infections.

    • Exclusion Criteria: Community-acquired cases.

  3. Quality Dimension: Safety, Effectiveness

  4. Indicator Type: Outcome

  5. Sampling Techniques: All blood cultures.

  6. Formula: (MRSA events / Patient-days) × 1,000

  7. Frequency: Quarterly

  8. Source of Data: Lab, records

  9. Methodology: LabID surveillance; calculate SIR.

  10. Target / Benchmark: 50% reduction from baseline (CDC/HHS)

    2 sources

  11. Explanation: This KPI monitors resistant staph infections.

 

7. Vancomycin-Resistant Enterococci (VRE) Infection Rate

  1. Indicator Title: Vancomycin-Resistant Enterococci (VRE) Infection Rate

  2. Definition: Number of VRE infections per patient-days.

    • Inclusion Criteria: Hospital-acquired VRE cases.

    • Exclusion Criteria: Colonization without infection.

  3. Quality Dimension: Safety, Effectiveness

  4. Indicator Type: Outcome

  5. Sampling Techniques: All cultures.

  6. Formula: (VRE infections / Patient-days) × 1,000

  7. Frequency: Quarterly

  8. Source of Data: Lab reports

  9. Methodology: Surveillance for resistant enterococci; calculate rate.

  10. Target / Benchmark: SIR <1 (CDC NHSN)

    2 sources

  11. Explanation: This KPI tracks vancomycin-resistant gut bacteria infections.

 

8. Extended-Spectrum Beta-Lactamase (ESBL)-Producing Enterobacteriaceae Rate

  1. Indicator Title: Extended-Spectrum Beta-Lactamase (ESBL)-Producing Enterobacteriaceae Rate

  2. Definition: Number of ESBL infections per patient-days.

    • Inclusion Criteria: ESBL-positive Enterobacterales infections.

    • Exclusion Criteria: Non-ESBL strains.

  3. Quality Dimension: Safety, Effectiveness

  4. Indicator Type: Outcome

  5. Sampling Techniques: Lab surveillance.

  6. Formula: (ESBL infections / Patient-days) × 1,000

  7. Frequency: Quarterly

  8. Source of Data: Microbiology labs

  9. Methodology: Detect ESBL via testing; calculate incidence.

  10. Target / Benchmark: Varies by region, aim for reduction (ECDC)

    2 sources

  11. Explanation: This KPI addresses beta-lactam resistant bacteria.

 

9. Carbapenem-Resistant Enterobacteriaceae (CRE) Rate

  1. Indicator Title: Carbapenem-Resistant Enterobacteriaceae (CRE) Rate

  2. Definition: Number of CRE infections per patient-days.

    • Inclusion Criteria: Carbapenem-resistant Enterobacterales.

    • Exclusion Criteria: Susceptible strains.

  3. Quality Dimension: Safety, Effectiveness

  4. Indicator Type: Outcome

  5. Sampling Techniques: All high-risk screenings.

  6. Formula: (CRE infections / Patient-days) × 1,000

  7. Frequency: Quarterly

  8. Source of Data: Lab, surveillance

  9. Methodology: Use resistance criteria; calculate SIR.

  10. Target / Benchmark: 0 (CDC target)

    2 sources

  11. Explanation: This KPI focuses on highly resistant CRE.

 

10. Multidrug-Resistant Pseudomonas aeruginosa Rate

  1. Indicator Title: Multidrug-Resistant Pseudomonas aeruginosa Rate

  2. Definition: Number of MDR P. aeruginosa infections per patient-days.

    • Inclusion Criteria: MDR strains per definition.

    • Exclusion Criteria: Susceptible P. aeruginosa.

  3. Quality Dimension: Safety, Effectiveness

  4. Indicator Type: Outcome

  5. Sampling Techniques: Lab isolates.

  6. Formula: (MDR P. aeruginosa / Patient-days) × 1,000

  7. Frequency: Quarterly

  8. Source of Data: Microbiology

  9. Methodology: Test for resistance; calculate rate.

  10. Target / Benchmark: <20% resistance (WHO)

    2 sources

  11. Explanation: This KPI tracks resistant Pseudomonas.

 

11. Multidrug-Resistant Acinetobacter baumannii Rate

  1. Indicator Title: Multidrug-Resistant Acinetobacter baumannii Rate

  2. Definition: Number of MDR A. baumannii infections per patient-days.

    • Inclusion Criteria: MDR strains.

    • Exclusion Criteria: Susceptible strains.

  3. Quality Dimension: Safety, Effectiveness

  4. Indicator Type: Outcome

  5. Sampling Techniques: Lab surveillance.

  6. Formula: (MDR A. baumannii / Patient-days) × 1,000

  7. Frequency: Quarterly

  8. Source of Data: Lab reports

  9. Methodology: Define MDR; calculate incidence.

  10. Target / Benchmark: Reduction to <10% (ECDC)

    2 sources

  11. Explanation: This KPI monitors resistant Acinetobacter.

 

12. Overall Healthcare-Associated Infection (HAI) Incidence Rate

  1. Indicator Title: Overall Healthcare-Associated Infection (HAI) Incidence Rate

  2. Definition: Number of HAIs per patient-days.

    • Inclusion Criteria: All hospital-acquired infections.

    • Exclusion Criteria: Community-acquired.

  3. Quality Dimension: Safety, Effectiveness

  4. Indicator Type: Outcome

  5. Sampling Techniques: Facility-wide surveillance.

  6. Formula: (HAIs / Patient-days) × 1,000

  7. Frequency: Annually

  8. Source of Data: Surveillance data

  9. Methodology: Aggregate HAI types; calculate rate.

  10. Target / Benchmark: 5-10% reduction yearly (CDC)

    2 sources

  11. Explanation: This KPI provides a broad view of infection burden.

 

13. Bloodstream Infection (BSI) Rate (Non-Device Associated)

  1. Indicator Title: Bloodstream Infection (BSI) Rate (Non-Device Associated)

  2. Definition: Number of non-device BSIs per patient-days.

    • Inclusion Criteria: BSIs not linked to devices.

    • Exclusion Criteria: Device-associated BSIs.

  3. Quality Dimension: Safety, Effectiveness

  4. Indicator Type: Outcome

  5. Sampling Techniques: All blood cultures.

  6. Formula: (Non-device BSIs / Patient-days) × 1,000

  7. Frequency: Quarterly

  8. Source of Data: Lab reports

  9. Methodology: Exclude device-related; calculate rate.

  10. Target / Benchmark: <1 per 1,000 (ECDC HAI-Net)

    2 sources

  11. Explanation: This KPI identifies non-device sources of BSIs.

 

14. Urinary Tract Infection (UTI) Rate (Non-Catheter)

  1. Indicator Title: Urinary Tract Infection (UTI) Rate (Non-Catheter)

  2. Definition: Number of non-catheter UTIs per patient-days.

    • Inclusion Criteria: UTIs not linked to catheters.

    • Exclusion Criteria: Catheter-associated UTIs.

  3. Quality Dimension: Safety, Effectiveness

  4. Indicator Type: Outcome

  5. Sampling Techniques: All urine cultures.

  6. Formula: (Non-catheter UTIs / Patient-days) × 1,000

  7. Frequency: Quarterly

  8. Source of Data: Lab, records

  9. Methodology: Exclude catheter-related; calculate rate.

  10. Target / Benchmark: <2 per 1,000 (CDC)

    2 sources

  11. Explanation: This KPI highlights non-device UTI risks.

 

15. Pneumonia Rate (Non-Ventilator)

  1. Indicator Title: Pneumonia Rate (Non-Ventilator)

  2. Definition: Number of non-ventilator pneumonias per patient-days.

    • Inclusion Criteria: Hospital-acquired non-VAP.

    • Exclusion Criteria: Ventilator-associated cases.

  3. Quality Dimension: Safety, Effectiveness

  4. Indicator Type: Outcome

  5. Sampling Techniques: All pneumonia diagnoses.

  6. Formula: (Non-VAP pneumonias / Patient-days) × 1,000

  7. Frequency: Quarterly

  8. Source of Data: Clinical records

  9. Methodology: Use diagnostic criteria; calculate rate.

  10. Target / Benchmark: <3 per 1,000 (SHEA)

    2 sources

  11. Explanation: This KPI addresses NV-HAP, a common HAI.

 

16. Antibiotic Utilization Rate (e.g., Days of Therapy per 1,000 Patient-Days)

  1. Indicator Title: Antibiotic Utilization Rate (e.g., Days of Therapy per 1,000 Patient-Days)

  2. Definition: Days of antibiotic therapy normalized to patient-days.

    • Inclusion Criteria: All antibiotic days.

    • Exclusion Criteria: Non-antibiotic therapies.

  3. Quality Dimension: Effectiveness, Efficiency

  4. Indicator Type: Outcome

  5. Sampling Techniques: Pharmacy data review.

  6. Formula: (Total DOT / Patient-days) × 1,000

  7. Frequency: Monthly

  8. Source of Data: Pharmacy records

  9. Methodology: Aggregate DOT; normalize.

  10. Target / Benchmark: Varies, e.g., <800 DOT/1,000 (CDC)

    2 sources

  11. Explanation: This KPI evaluates stewardship by tracking antibiotic consumption.

 

17. Contamination Incidence Rate

  1. Indicator Title: Contamination Incidence Rate

  2. Definition: Rate of environmental or equipment contamination events.

    • Inclusion Criteria: Detected contamination incidents.

    • Exclusion Criteria: Non-healthcare related.

  3. Quality Dimension: Safety

  4. Indicator Type: Outcome

  5. Sampling Techniques: Swab testing.

  6. Formula: (Contamination events / Patient-days) × 1,000

  7. Frequency: Quarterly

  8. Source of Data: Environmental swabs

  9. Methodology: Test surfaces; calculate incidence.

  10. Target / Benchmark: <5% positive (APIC)

    2 sources

  11. Explanation: This KPI detects contamination risks.

 

18. Patient Satisfaction with IPC Measures

  1. Indicator Title: Patient Satisfaction with IPC Measures

  2. Definition: Percentage of patients satisfied with IPC practices.

    • Inclusion Criteria: All surveyed patients.

    • Exclusion Criteria: Non-respondents.

  3. Quality Dimension: Patient-centeredness

  4. Indicator Type: Outcome

  5. Sampling Techniques: Post-discharge surveys.

  6. Formula: (Satisfied responses / Total responses) × 100

  7. Frequency: Annually

  8. Source of Data: Patient surveys

  9. Methodology: Collect feedback; calculate score.

  10. Target / Benchmark: >90% (WHO)

    2 sources

  11. Explanation: This KPI gauges patient perceptions of IPC efforts.

© 2017 by Dr Amir Monir 

bottom of page